Pioneer of mushroom cultivation
“The future of the medicinal mushroom industry lies not in the traditional agricultural model, but in the transition to a laboratory-based biological production process. Mushrooms are more than just food—they are pharmaceutical raw materials, construction materials, soil conditioners, and the foundation for a new generation of biotechnological products. Their full potential can only be realized through the combination of engineering precision, mycological expertise, and entrepreneurial vision.”
This conviction shapes the work of PhD(H) John C. Holliday—a mechanical engineer, mycologist, and entrepreneur who is now regarded as one of the world’s leading experts on medicinal mushrooms, fungal biotechnology, and industrial mushroom production. As the founder and former president of Aloha Medicinals Inc. (1999–2017), with two U.S. patents and experience advising over 100 mushroom cultivation facilities in more than 20 countries, he has elevated both the medicinal mushroom industry and biotechnological mushroom production to a scientifically sound and industrially scalable level.
After graduating from high school in Titusville, Florida (1974), his passion for education led him to forge a unique self-directed educational path. Building on this foundation, he pursued his studies during his military service (1974–1977): engineering courses at the U.S. Army Engineer School in Ft. Belvoir, Virginia; courses at Kansas State University; an AA degree in Conservation from the National School of Conservation in Washington, D.C. (1974); and an AS degree in Automotive Technology from the Advanced Technical Schools in Chicago (1976). By 1977, he had earned the equivalent of a bachelor’s degree in mechanical engineering. From 1978 to 1981, he studied at Heidelberg University in Germany. In 1998, he was awarded an honorary doctorate (H) in mycological pharmacology by Zhejiang University in Hangzhou, China, for his work on the cultivation of Agaricus blazei, a rare South American mushroom with anti-cancer properties. From 1977 to 1984, he worked as a mechanical engineer for Harris Satellite Corp, ITT Inc, Western Geophysical Inc, Teledyne Exploration Inc, and Hawaiian Commercial and Sugar Company Inc.
Since 1984, his professional work has focused on the design and construction of specialized machinery. As a freelance mechanical engineer (1984–1999), he designed high-pressure air systems for U.S. Navy nuclear submarines and other specialized systems. In February 1999, he founded Aloha Medicinals Inc. in Hawaii after discovering a unique market niche: While there was extensive research on medically important compounds found in exotic mushroom species, there was no real medicinal mushroom industry in North America. He works with over 1,000 pharmaceutical and dietary supplement manufacturers in more than 65 countries to supply raw materials for the pharmaceutical and nutraceutical industries, as well as finished dietary supplements. In doing so, he places great emphasis on combining engineering expertise with mycological knowledge and entrepreneurial foresight.
A central focus of his work is the optimization and automation of mushroom cultivation using machines he has designed and built himself. He is dedicated to transforming the traditional agricultural model of mushroom cultivation into a laboratory-based biological production process, thereby creating a new industry.
His entrepreneurial career has seen impressive growth: In 2002, he relocated Aloha Medicinals to Santa Cruz, California, and merged with Stoller Research, a mushroom research facility established in 1955. In 2007, the company moved to Carson City, Nevada. By 2008, exports accounted for 65% of revenue, and by 2012, the company had opened branches in Europe, Asia, Africa, and Mexico. Revenue grew steadily by over 25% per year. In 2016, Aloha Medicinals was sold to an investment firm specializing in biotech manufacturing companies. For his work, he received the U.S. Department of Commerce’s “Small Business Exporter of the Year” award two years in a row in 2008 and 2009, as well as the Nevada Governors Award for Business Excellence in 2008.
In addition to Aloha Medicinals, he has provided design, construction, and/or consulting services to well over 100 mushroom farms in more than 20 countries worldwide—for edible mushrooms, medicinal mushrooms, and mushrooms used in industrial applications such as building materials, agricultural soil amendments, animal feed, and meat and protein products from non-animal sources.
He has published several dozen scientific articles in peer-reviewed journals and authored two chapters in reference books: “Cordyceps” in the Encyclopedia of Dietary Supplements (a standard reference work of the FDA) and “Cordyceps – a Highly Coveted Medicinal Mushroom” for the book “Medicinal Plants and Fungi: Recent Advances in Research and Development.” He is a member of the editorial board of the “International Journal of Medicinal Mushrooms,” the leading journal in this field of science. He has been granted two U.S. patents (7,407,795 and 8,008,060), with six additional patents pending.
As Vice President of the International Society for Medicinal Mushrooms, mycology advisor to the Government of Ghana, Vice President of the African Society for Edible and Medicinal Mushrooms, and a member of the Scientific Committee for all International Conferences on Medicinal Mushrooms (from the 2nd IMCC in 2003 to the current 12th IMMC), he has played a pivotal role in shaping the global development of medicinal mushroom research. As a visiting professor, he has lectured at universities worldwide, including Harvard Medical School, MIT, UCLA, UC Santa Cruz, the University of Nevada, Reno, and many others.
He knows how to combine mechanical engineering with mycology and entrepreneurial vision, and advocates for an integrative understanding of innovation—as the interplay of technical precision, scientific expertise, and economic scalability. His work makes it clear that, for him, fungi are not merely objects of research, but the foundation of a global biotechnology industry that unites pharmaceutical, nutritional, and industrial applications. At the Mycoverse Foundation, he contributes his expertise in mycological pharmacology, biotechnological production, quality assurance (QA/QC), regulatory affairs, and international business development, helping not only to explore the potential of medicinal mushrooms but also to translate it into industrially scalable, regulatory-compliant products—and to develop a new generation of biotechnological applications.
His 18 years of experience in corporate management, with responsibilities spanning multiple continents, his expertise in all aspects of FDA regulation, and his extensive skills in business development, leadership, and international exports are particularly valuable for the commercial implementation of mycological innovations. In this way, he makes a significant contribution to a future that is technically precise, scientifically sound, and economically viable—and in which the medicinal mushroom industry is recognized as an established sector of biotechnology.
Roger Scott – (775) 750-6070
Dan Ailes – (775) 886-6300
Rebecca Barrows – (775) 291-7613
Jason Watkins – (877) 746-9397
Mycoverse Foundation
, Marktgass 11,
, 9490 Vaduz,
, Principality of Liechtenstein
Home | Vision | Projekte | Artikel | Vorstand/Beirat | Shop | Kontakt | Impressum/Datenschutz | Manage Cookie Settings